Inventor
MADERNA ANDREAS
US28 patents
⚠️ This page may combine multiple inventors who share the name “MADERNA ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
13 patentsUS8828401B2Sep 9, 2014
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER35 citations92
US9249186B2Feb 2, 2016
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER7 citations82
US9138486B2Sep 22, 2015
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER7 citations82
US10538542B2Jan 21, 2020
Cyclopentane-based modulators of STING (stimulator of interferon genes)
PFIZER4 citations71
US10662204B2May 26, 2020
Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agents
PFIZER4 citations70
US10590115B2Mar 17, 2020
Tetrahydroquinazoline derivatives useful as anticancer agents
PFIZER2 citations70
US10086085B2Oct 2, 2018
Bifunctional cytotoxic agents
PFIZER2 citations67
US11365263B2Jun 21, 2022
Bifunctional cytotoxic agents containing the CTI pharmacophore
PFIZER0 citations59
US10968242B2Apr 6, 2021
Cyclopentane-based modulators of STING (stimulator of interferon genes)
PFIZER1 citations59
US9873690B2Jan 23, 2018
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER1 citations49
US10870706B2Dec 22, 2020
Bifunctional cytotoxic agents containing the CTI pharmacophore
PFIZER0 citations48
US10391182B2Aug 27, 2019
Bifunctional cytotoxic agents
PFIZER0 citations46
US10544095B2Jan 28, 2020
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER0 citations38
ARDEA BIOSCIENCES INC
5 patentsUS7820664B2Oct 26, 2010
Inhibitors of MEK
ARDEA BIOSCIENCES INC37 citations92
US7429667B2Sep 30, 2008
Phenylamino isothiazole carboxamidines as MEK inhibitors
ARDEA BIOSCIENCES INC7 citations71
US8884058B2Nov 11, 2014
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
ARDEA BIOSCIENCES INC2 citations63
US7652047B2Jan 26, 2010
Phenylamino isothiazole carboxamidines as MEK inhibitors
ARDEA BIOSCIENCES INC4 citations60
US9296686B2Mar 29, 2016
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
ARDEA BIOSCIENCES INC0 citations52
SUTRO BIOPHARMA INC
4 patentsUS11744876B2Sep 5, 2023
Immunomodulator antibody drug conjugates and uses thereof
SUTRO BIOPHARMA INC4 citations71
US12226490B2Feb 18, 2025
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class
SUTRO BIOPHARMA INC0 citations57
US12144869B2Nov 19, 2024
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates
SUTRO BIOPHARMA INC0 citations57
US12534465B2Jan 27, 2026
5H-pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds and antibody conjugates thereof
SUTRO BIOPHARMA INC0 citations49
MADERNA ANDREAS
3 patentsUS8101799B2Jan 24, 2012
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
MADERNA ANDREAS28 citations90
US8513443B2Aug 20, 2013
Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-3,4-difluoro-2(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
MADERNA ANDREAS4 citations72
US8829052B2Sep 9, 2014
Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
MADERNA ANDREAS1 citations57